IDX

How do I buy IDX shares in Australia?

Buying IDX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Integral Diagnostics Limited in minutes.

1. Sign up with some I.D. and zero paperwork
2. Add funds to your account
3. Make your first investment in IDX

---

What is the ticker symbol of Integral Diagnostics Limited?

The ticker symbol for Integral Diagnostics Limited is IDX.

---

How much is one share of IDX?

One share of IDX is valued at $2.11 as of 15 October 2026.

---

What is the market capitalisation of Integral Diagnostics Limited IDX?

As of 15 October 2026 Integral Diagnostics Limited has a market cap of $788.5M.

---

Does IDX pay dividends?

Yes, IDX does pay dividends.

---

What is the dividend yield for IDX?

The dividend yield for IDX is 4.43% as of 15 October 2026.

---

How much dividends does IDX pay?

The most recent IDX dividend distribution paid $0.06 per share on 02 October 2026.

---

What is the IDX ex-dividend date?

The ex-dividend date of IDX was 28 August 2026.

---

What is the P/E ratio of IDX?

The Price to Earnings ratio of IDX is 36.38.

---

What is the Earnings Per Share of IDX?

The Earnings Per Share of IDX is $0.06.

---

What is the 52-week high for Integral Diagnostics Limited stock?

The Integral Diagnostics Limited 52-week high stock price is $2.71.

---

What is the 52-week low for Integral Diagnostics Limited stock?

The Integral Diagnostics Limited 52-week low stock price is $1.91.

---

Can I buy IDX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake investing platform allows you to buy IDX shares and over 13,000 more stocks and ETFs across the ASX and Wall St.

---

This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.